JPRN-jRCT2080220941未知1 期
A Phase I/II Study of S-1 in Combination with Sorafenib in Patients with Metastatic Renal Cell Cancer.
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1)Patients with renal cell carcinoma metastases who underwent nephrectomy(with histological confirmation)
- •2)Patients had not received previous treatment for renal cell carcinoma. Or patients had progressed after one cytokine therapy
排除标准
- •1)Patients with active peptic ulcer
- •2)Patients with skin disease under medical treatment
- •3)Patients with uncontrolled hypertension
- •4)Patients with diarrhea
- •5)Patients with brain metastases
- •6)Patients with multiple carcinoma
研究者
相似试验
已完成
2 期
A Multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanved non-squamous non-small cell lung cancerJPRN-UMIN000007386Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine28
已完成
不适用
Phase I/II study of S-1 plus intravenous and intraperitoneal paclitaxel for pancreas cancer with peritoneal metastasisThe patients with pancreatic cancer who have peritoneal metastasis diagnosed by staging laparoscopy or open laparotomy.JPRN-UMIN000009446Study group of pancreatic cancer with peritoneal metastasis33
已完成
2 期
A phase II study of S-1 (14days-administrarion followed by 7days-rest ) for Metastatic Breast CancerBreast CancerJPRN-UMIN000014096Tokyo Women's Medical University25
已完成
不适用
Phase II study of S-1 combined with irinotecan in patients with advanced colorectal cancerJPRN-UMIN000001741Showa University School of Medicin40
已完成
不适用
A phase I/II study of combination therapy with S-1/ CPT-11 plus Panitumumab as second line therapy in metastatic colorectal cancer patients with KRAS wild typeJPRN-UMIN000005218Fukuoka Tumor Research(FUTURE)